Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: Identification of (S)-N-[1-(4-fluoro-3-morpholin-4-ylphenyl)ethyl]-3-(4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibition

  • Yong Jin Wu
  • , Carl D. Davis
  • , Steven Dworetzky
  • , William C. Fitzpatrick
  • , David Harden
  • , Huan He
  • , Ronald J. Knox
  • , Amy E. Newton
  • , Thomas Philip
  • , Craig Polson
  • , Digavalli V. Sivarao
  • , Li Qiang Sun
  • , Svetlana Tertyshnikova
  • , David Weaver
  • , Suresh Yeola
  • , Mary Zoeckler
  • , Michael W. Sinz

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)3778-3781
Number of pages4
JournalJournal of Medicinal Chemistry
Volume46
Issue number18
DOIs
StatePublished - Aug 2003

ASJC Scopus Subject Areas

  • Molecular Medicine
  • Drug Discovery

Cite this